peter attia tirzepatide How do Semaglutide and work, and why are they transforming diabetes and obesity care worldwide? Join our expert-led webinar to explore the science, clinical evidence, and real-world impact of these breakthrough GLP-1s and aging: Peter Attia

Practical Application in Healthcare When to Consider Semaglutide: Semaglutide should be considered for patients with Type 2 diabetes who are at risk of kidney disease or are already showing signs of kidney damage, such as proteinuria or declining GFR

GLP-1 RAs May Reduce Metastatic Progression in Certain Obesity-Related Cancers

Our guarantee means GLP-1 treatments are now within reach, so you can finally achieve the sustainable weight loss results you want

Scientists use BPC-157 peptide to investigate fundamental cellular and tissue-level signaling mechanisms

Key Benefits of Tesamorelin Targeted visceral fat reduction in the abdominal cavity Improved metabolic markers, including triglyceride levels and insulin sensitivity Enhanced cognition, sleep quality, and energy in individuals with GH deficiency Convenient once-daily injection Because visceral fat is linked to cardiovascular disease, insulin resistance, and type 2 diabetes, Tesamorelin plays a pivotal role in reducing cardiometabolic risk in affected populations